Please login to the form below
Impact of data sharing
With the General Data Protection Regulation (GDPR) on the horizon, the Cambridge Analytica scandal has provided a stark reminder of the importance of data protection laws.
With the General Data Protection Regulation (GDPR) on the horizon,
the Cambridge
Analytica scandal has provided a stark reminder of the importance of data
protection laws. Investigative journalists revealed that the data analytics firm harvested personal
information to inform political campaigns from Facebook users without their
permission, and last week Facebook confirmed that the number of users affected may be as
high as 87 million.
It wouldn’t be surprising if a data breach on this scale affected people’s confidence in data sharing of any kind, making them reluctant to allow their data to be shared under any circumstances. When data is used improperly it can leave people feeling betrayed, and stories highlighting examples of good data sharing are less newsworthy.
But big data has the potential to transform many areas of our lives, not least in healthcare. NHS data, used appropriately, can improve our understanding of disease, inform decisions on diagnosis and treatment, enhance safety monitoring, and drive the development of new treatments.
According to Understanding Patient Data, more than two thirds of the population don’t know how their data is used in the NHS. Their recent #datasaveslives campaign includes a series of great animations explaining how and why patient data can be harnessed to benefit all of us.
The issue of benefit is key – when patients are properly informed, and can see that the aim of any data sharing project will genuinely benefit others, they are more inclined to agree to their data being used; as people understand more about the benefits and risks involved, they become less sceptical about health data sharing.
GDPR will modernise the legal framework for privacy and the protection of personal data across the EU. It’s clear that there is an urgent need for enhanced public understanding of the issues around data sharing, so that big data can be used to transform patients’ lives.
It wouldn’t be surprising if a data breach on this scale affected people’s confidence in data sharing of any kind, making them reluctant to allow their data to be shared under any circumstances. When data is used improperly it can leave people feeling betrayed, and stories highlighting examples of good data sharing are less newsworthy.
But big data has the potential to transform many areas of our lives, not least in healthcare. NHS data, used appropriately, can improve our understanding of disease, inform decisions on diagnosis and treatment, enhance safety monitoring, and drive the development of new treatments.
According to Understanding Patient Data, more than two thirds of the population don’t know how their data is used in the NHS. Their recent #datasaveslives campaign includes a series of great animations explaining how and why patient data can be harnessed to benefit all of us.
The issue of benefit is key – when patients are properly informed, and can see that the aim of any data sharing project will genuinely benefit others, they are more inclined to agree to their data being used; as people understand more about the benefits and risks involved, they become less sceptical about health data sharing.
GDPR will modernise the legal framework for privacy and the protection of personal data across the EU. It’s clear that there is an urgent need for enhanced public understanding of the issues around data sharing, so that big data can be used to transform patients’ lives.
Latest content on this profile
- Call for industry innovators to join working group
- The IBD Registry is calling for industry stakeholders with a flair for innovation and collaboration to join its Industry Working Group.
Dovetail
- IBD Registry wins Communiqué award for COVID-19 tool
- The IBD Registry has won a coveted Communiqué award in recognition of its collaborative efforts in creating the COVID-19 IBD Risk Tool for people with inflammatory bowel disease (IBD).
Dovetail
- DOVETAIL & IBD REGISTRY WIN AGILITY AND FLEXIBILITY AWARD AT COMMUNIQUÉ 2021
- The award was the first to be won in Communiqué’s new AGILITY AND FLEXIBILITY category.
Dovetail
- Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe
- Specialist stakeholder engagement consultancy Dovetail, based in London, UK, have announced a new partnership with Tillotts Pharma AG to support the launch of Tillotts’ recent acquisition DIFICLIR™ in the EU.
Dovetail
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Specialist healthcare consultancy Dovetail launches new collaboration skills training in response to client demand.
Dovetail
- Joint working that works
Dovetail
